https://www.glp1observer.com/archivedailyhttps://www.glp1observer.com/aboutweeklyhttps://www.glp1observer.com/p/oral-race-open-questions2026-04-03monthlyhttps://www.glp1observer.com/p/enzymes-and-early-signals2026-03-28monthlyhttps://www.glp1observer.com/p/approvals-pills-and-brain-rewards2026-03-20monthlyhttps://www.glp1observer.com/p/genes-inflammation-and-a-truce2026-03-13monthlyhttps://www.glp1observer.com/p/milestones-muscle-and-missing-the2026-03-06monthlyhttps://www.glp1observer.com/p/pills-implants-and-price-cuts2026-02-27monthlyhttps://www.glp1observer.com/p/plateaus-psoriasis-and-persistent2026-02-20monthlyhttps://www.glp1observer.com/p/pivots-patents-and-peptide-conjugates2026-02-13monthlyhttps://www.glp1observer.com/p/heartbeats-sleep-and-earnings2026-02-06monthlyhttps://www.glp1observer.com/p/225-table-stakes-and-the-gila-monster2026-01-30monthlyhttps://www.glp1observer.com/p/airlines-groceries-and-amylin2026-01-23monthlyhttps://www.glp1observer.com/p/from-peptides-to-genetic-medicine2026-01-16monthlyhttps://www.glp1observer.com/p/oral-wegovy-hits-shelves-and-the2026-01-10monthlyhttps://www.glp1observer.com/p/year-end-patent-news-and-phase-32026-01-06monthlyhttps://www.glp1observer.com/p/an-oral-milestone-for-glp-12025-12-27monthlyhttps://www.glp1observer.com/p/cagrisema-and-orforglipron-head-to2025-12-19monthlyhttps://www.glp1observer.com/p/oral-bets-and-multi-target-comparisons2025-12-12monthlyhttps://www.glp1observer.com/p/global-guidelines-and-pipeline-updates2025-12-08monthlyhttps://www.glp1observer.com/p/alzheimers-setback-and-next-gen-weight2025-12-04monthlyhttps://www.glp1observer.com/p/oral-outcomes-and-phase-3-milestones2025-12-04monthlyhttps://www.glp1observer.com/p/glp-1s-in-mash-and-sleep-apnea2025-12-04monthlyhttps://www.glp1observer.com/p/pricing-deals-and-obesityweek-announcements2025-12-04monthlyhttps://www.glp1observer.com/p/bidding-for-innovation2025-12-04monthlyhttps://www.glp1observer.com/p/more-than-body-fat-reduction2025-12-04monthlyhttps://www.glp1observer.com/p/government-shutdown-affects-new-trials2025-12-04monthlyhttps://www.glp1observer.com/p/glp-1-landscape-59e2025-12-04monthlyhttps://www.glp1observer.com/p/welcome-to-glp-1-observer2025-12-04monthlyhttps://www.glp1observer.com/p/glp-1-landscape2025-10-08monthly